Discovery of new source of cancer antigens may expand cancer vaccine capabilities
Scientists have found a common, new source of tumor mutations that could offer three levels of therapy with a cancer vaccine: 1) a broadly protective, or pan-cancer vaccine 2) cancer-type specific vaccines (e.g. breast vs. pancreatic), 3) personalized cancer vaccines based on mutations unique to an individual.
Read Original Article: Discovery of new source of cancer antigens may expand cancer vaccine capabilities »
